THIOTHIXENE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Thiothixene Hydrochloride, and when can generic versions of Thiothixene Hydrochloride launch?
Thiothixene Hydrochloride is a drug marketed by Alpharma Us Pharms, Paco, Teva, Teva Pharms, and Hikma. and is included in six NDAs.
The generic ingredient in THIOTHIXENE HYDROCHLORIDE is thiothixene hydrochloride. There are six drug master file entries for this compound. Additional details are available on the thiothixene hydrochloride profile page.
Summary for THIOTHIXENE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 65 |
| Clinical Trials: | 4 |
| Patent Applications: | 6,064 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | THIOTHIXENE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for THIOTHIXENE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Lindner Center of HOPE | Phase 2 |
| Janssen Scientific Affairs, LLC | |
| Canadian Institutes of Health Research (CIHR) |
US Patents and Regulatory Information for THIOTHIXENE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpharma Us Pharms | THIOTHIXENE HYDROCHLORIDE | thiothixene hydrochloride | CONCENTRATE;ORAL | 070969-001 | Oct 16, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Teva | THIOTHIXENE HYDROCHLORIDE | thiothixene hydrochloride | CONCENTRATE;ORAL | 071184-001 | Jun 22, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Paco | THIOTHIXENE HYDROCHLORIDE | thiothixene hydrochloride | CONCENTRATE;ORAL | 071917-001 | Sep 20, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
